Korlym (Mifepristone) for Treatment of Endogenous Cushing’s Syndrome

Korlym (mifepristone) is a glucocorticoid receptor blocker indicated for the control of high blood sugar levels in adult patients suffering from endogenous Cushing's syndrome.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news